Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01667042 · ClinicalTrials.gov registry record

Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
7
Enrollment target

NCT01667042: Completed study, sponsored by Mayo Clinic.

NCT01667042 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01667042 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
7 participants
Enrollment target

Study Summary

This is a mechanistic research study to evaluate the relationship between cough, reflux, and aspiration in patients with systemic sclerosis (scleroderma).

Primary Outcome

Cross-sectional comparison between airway pepsin level, cough frequency, FVC, DLCO, and CT fibrosis score

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2012-08
Est. Completion 2015-06
Mayo Clinic

2,844 total trials

What the finished NCT01667042 record still lists

NCT01667042 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01667042 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01667042 about?

NCT01667042 is a clinical study titled "Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough". This is a mechanistic research study to evaluate the relationship between cough, reflux, and aspiration in patients with systemic sclerosis (scleroderma).

What is the current status of trial NCT01667042?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2012-08. Estimated completion is 2015-06.

Who is sponsoring clinical trial NCT01667042?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01667042, the US trial registry maintained by the National Library of Medicine. NCT01667042 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.